Why is Pfizer Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 2.39% and Operating profit at 7.42% over the last 5 years
2
Flat results in Dec 25
- INVENTORY TURNOVER RATIO(HY) Lowest at 4.75 times
- DEBTORS TURNOVER RATIO(HY) Lowest at 9.74 times
3
With ROE of 19.8, it has a Very Expensive valuation with a 5.6 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 15.60%, its profits have risen by 23.8% ; the PEG ratio of the company is 1.2
- At the current price, the company has a high dividend yield of 3.5
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Pfizer for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Pfizer
15.6%
0.60
26.04%
Sensex
-1.65%
-0.13
12.27%
Quality key factors
Factor
Value
Sales Growth (5y)
2.39%
EBIT Growth (5y)
7.42%
EBIT to Interest (avg)
59.60
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.69
Sales to Capital Employed (avg)
0.74
Tax Ratio
24.64%
Dividend Payout Ratio
119.20%
Pledged Shares
0
Institutional Holding
19.76%
ROCE (avg)
49.32%
ROE (avg)
18.68%
Valuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
32
Price to Book Value
5.61
EV to EBIT
22.61
EV to EBITDA
21.11
EV to Capital Employed
15.92
EV to Sales
7.62
PEG Ratio
1.19
Dividend Yield
3.50%
ROCE (Latest)
63.46%
ROE (Latest)
19.81%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
Technical Movement
8What is working for the Company
PAT(9M)
At Rs 565.62 cr has Grown at 29.53%
ROCE(HY)
Highest at 24.41%
NET SALES(Q)
Highest at Rs 645.03 cr
-3What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 4.75 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 9.74 times
Loading Valuation Snapshot...
Here's what is working for Pfizer
Net Sales - Quarterly
Highest at Rs 645.03 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Latest six months
At Rs 373.87 cr has Grown at 30.75%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Pfizer
Inventory Turnover Ratio- Half Yearly
Lowest at 4.75 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio- Half Yearly
Lowest at 9.74 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio






